Semi-mechanistic population pharmacokinetics analysis reveals distinct CYP2C19 dependency in the bioactivation of vicagrel and clopidogrel to active metabolite M15

Semi-mechanistic population pharmacokinetics analysis reveals distinct CYP2C19 dependency in the bioactivation of vicagrel and clopidogrel to active metabolite M15–2

Published:2022-10 Issue: Volume:177 Page:106264
ISSN:0928-0987
Container-title:European Journal of Pharmaceutical Sciences
language:en
Short-container-title:European Journal of Pharmaceutical Sciences

Author:

Zhang Lin,Sun Hongbin,Liu Yongqiang,Lai Xiaojuan,Gong Yanchun,Liu Xuefang,Li Yong-guo,He Yang,Zhang Eric Y,Yan Xiaoyu

Publisher

Elsevier BV

Subject

Pharmaceutical Science

Reference36 articles.

1. Beal, S.L., Sheiner, L.B., Boeckmann, A.J. & Bauer, R.J., 1989-2018. NONMEM 7.4 users guides.

2. Genetic polymorphism analysis of CYP2C19 in Chinese Han populations from different geographic areas of mainland China;Chen;Pharmacogenomics,2008

3. Influence of genetic co-factors on the population pharmacokinetic model for clopidogrel and its active thiol metabolite;Danielak;Eur. J. Clin. Pharmacol.,2017

4. Cytochromes P450 catalyze both steps of the major pathway of clopidogrel bioactivation, whereas paraoxonase catalyzes the formation of a minor thiol metabolite isomer;Dansette;Chem. Res. Toxicol.,2012

5. FDA, 2010. Drug Safety Communication: Reduced effectiveness of Plavix (Clopidogrel) in Patients Who are Poor Metabolizers of the Drug.

Cited by 1 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Integrating Clopidogrel’s First-Pass Effect in a Joint Semi-Physiological Population Pharmacokinetic Model of the Drug and Its Inactive Carboxylic Acid Metabolite;Pharmaceutics;2024-05-20